ARCHIVES

Clinical Trials Approved By NCI

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003